Collectively, our findings illuminate a previously undescribed post-translation mechanism in which AMPK activity is regulated by E3 ubiquitin ligase and provides an attractive therapeutic strategy for the treatment of obesity and its related comorbidities. This evidence concerns the gene PRKAA1 and obesity due to melanocortin 4 receptor deficiency.